Trinucleotide repeat disorders.
暂无分享,去创建一个
[1] R. Nussbaum,et al. The protein product of the fragile X gene, FMR1, has characteristics of an RNA-binding protein , 1993, Cell.
[2] C. Ross,et al. A repeat expansion in the gene encoding junctophilin-3 is associated with Huntington disease–like 2 , 2001, Nature Genetics.
[3] A. Hilliker,et al. RNAi-mediated suppression of the mitochondrial iron chaperone, frataxin, in Drosophila. , 2005, Human molecular genetics.
[4] D. Pietrobon,et al. Calcium channels and channelopathies of the central nervous system , 2002, Molecular Neurobiology.
[5] D. Richardson,et al. Development of potential iron chelators for the treatment of Friedreich's ataxia: ligands that mobilize mitochondrial iron. , 2001, Biochimica et biophysica acta.
[6] M. Koenig,et al. Evolution of the Friedreich's ataxia trinucleotide repeat expansion: founder effect and premutations. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[7] M. Porteous,et al. Dentatorubral and pallidoluysian atrophy (DRPLA) Clinical and neuropathological findings in genetically confirmed north american and european pedigrees , 1997, Movement disorders : official journal of the Movement Disorder Society.
[8] C. Amemiya,et al. Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene. , 1992, Science.
[9] A. Munnich,et al. Idebenone and reduced cardiac hypertrophy in Friedreich's ataxia , 2002, Heart.
[10] R. Kopito,et al. Impairment of the ubiquitin-proteasome system by protein aggregation. , 2001, Science.
[11] Janghoo Lim,et al. ATAXIN-1 Interacts with the Repressor Capicua in Its Native Complex to Cause SCA1 Neuropathology , 2006, Cell.
[12] S. Warren,et al. Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers. , 2001, Human molecular genetics.
[13] Control of dendritic development by the Drosophila fragile X-related gene involves the small GTPase Rac1 , 2003, Development.
[14] T. Cooper,et al. Transgenic mice expressing CUG-BP1 reproduce splicing mis-regulation observed in myotonic dystrophy. , 2005, Human molecular genetics.
[15] H. Zoghbi,et al. Interaction of Akt-Phosphorylated Ataxin-1 with 14-3-3 Mediates Neurodegeneration in Spinocerebellar Ataxia Type 1 , 2003, Cell.
[16] R. Carraway,et al. Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons , 1995, Neuron.
[17] Takanori Yamagata,et al. Large expansion of the ATTCT pentanucleotide repeat in spinocerebellar ataxia type 10 , 2000, Nature Genetics.
[18] S. Ceman,et al. Isolation of an FMRP-Associated Messenger Ribonucleoprotein Particle and Identification of Nucleolin and the Fragile X-Related Proteins as Components of the Complex , 1999, Molecular and Cellular Biology.
[19] M. Beal,et al. Neuroprotective Effects of Phenylbutyrate in the N171-82Q Transgenic Mouse Model of Huntington's Disease* , 2005, Journal of Biological Chemistry.
[20] Robin A. J. Smith,et al. Mitochondria‐targeted antioxidants protect Friedreich Ataxia fibroblasts from endogenous oxidative stress more effectively than untargeted antioxidants , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[21] C. Gellera,et al. The Friedreich's ataxia mutation confers cellular sensitivity to oxidant stress which is rescued by chelators of iron and calcium and inhibitors of apoptosis. , 1999, Human molecular genetics.
[22] R. Llinás,et al. Disturbed Ca2+ signaling and apoptosis of medium spiny neurons in Huntington's disease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[23] R. Vallee,et al. Fast transport and retrograde movement of huntingtin and HAP 1 in axons , 1997, Neuroreport.
[24] Peer Bork,et al. HEAT repeats in the Huntington's disease protein , 1995, Nature Genetics.
[25] I. Meinertzhagen,et al. Axonal Transport of Mitochondria to Synapses Depends on Milton, a Novel Drosophila Protein , 2002, Neuron.
[26] A. Riggs,et al. HnRNP H inhibits nuclear export of mRNA containing expanded CUG repeats and a distal branch point sequence , 2005, Nucleic acids research.
[27] S. Hersch,et al. Creatine therapy provides neuroprotection after onset of clinical symptoms in Huntington's disease transgenic mice , 2003, Journal of neurochemistry.
[28] G. Wang,et al. Cytoplasmic and Nuclear Retained DMPK mRNAs Are Targets for RNA Interference in Myotonic Dystrophy Cells* , 2005, Journal of Biological Chemistry.
[29] D. Housman,et al. Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[30] C. Fisch,et al. Coronary disease, cardioneuropathy, and conduction system abnormalities in the cardiomyopathy of Friedreich's ataxia. , 1987, British heart journal.
[31] Giuseppe Nicastro,et al. The solution structure of the Josephin domain of ataxin-3: structural determinants for molecular recognition. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[32] R. Paylor,et al. Fmr1 knockout mice are impaired in a leverpress escape/avoidance task , 2006, Genes, brain, and behavior.
[33] James M. Olson,et al. Therapeutic opportunities in polyglutamine disease , 2001, Nature Medicine.
[34] B. Van Houten,et al. Reduction in frataxin causes progressive accumulation of mitochondrial damage. , 2003, Human molecular genetics.
[35] F. Foury. Low iron concentration and aconitase deficiency in a yeast frataxin homologue deficient strain , 1999, FEBS letters.
[36] M. Tranfaglia,et al. Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP , 2005, Neuropharmacology.
[37] H. Diener,et al. Significance of MRI-confirmed atrophy of the cranial spinal cord in Friedreich's ataxia , 2004, European archives of psychiatry and neurological sciences.
[38] Jonathan Gray,et al. Rb regulates proliferation and rod photoreceptor development in the mouse retina , 2004, Nature Genetics.
[39] W. Brown,et al. Fragile X premutation tremor/ataxia syndrome: molecular, clinical, and neuroimaging correlates. , 2003, American journal of human genetics.
[40] B. Byrne,et al. Recruitment of human muscleblind proteins to (CUG)n expansions associated with myotonic dystrophy , 2000, The EMBO journal.
[41] I. Weiler,et al. Dendritic spine and dendritic field characteristics of layer V pyramidal neurons in the visual cortex of fragile-X knockout mice. , 2002, American journal of medical genetics.
[42] C. Ross,et al. SCA12: an unusual mutation leads to an unusual spinocerebellar ataxia , 2001, Brain Research Bulletin.
[43] Harry T Orr,et al. Recovery from Polyglutamine-Induced Neurodegeneration in Conditional SCA1 Transgenic Mice , 2004, The Journal of Neuroscience.
[44] Dimitri Krainc,et al. Transcriptional Repression of PGC-1α by Mutant Huntingtin Leads to Mitochondrial Dysfunction and Neurodegeneration , 2006, Cell.
[45] Denise S Walker,et al. Subunit interaction sites in voltage-dependent Ca2+ channels: role in channel function , 1998, Trends in Neurosciences.
[46] I. Scheffer,et al. Mutations in the human ortholog of Aristaless cause X-linked mental retardation and epilepsy , 2002, Nature Genetics.
[47] A. Joyner,et al. Inactivation of the mouse Huntington's disease gene homolog Hdh. , 1995, Science.
[48] T. Cooper,et al. Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. , 1998, Science.
[49] Stefan M Pulst,et al. Expansion of the polyQ repeat in ataxin-2 alters its Golgi localization, disrupts the Golgi complex and causes cell death. , 2003, Human molecular genetics.
[50] A. Kuwano,et al. Dentatorubral-pallidoluysian atrophy (DRPLA): clinical, genetic, and neuroradiologic studies in a family , 1995, Journal of the Neurological Sciences.
[51] Blair R. Leavitt,et al. Loss of Huntingtin-Mediated BDNF Gene Transcription in Huntington's Disease , 2001, Science.
[52] L. Pallanck,et al. A Drosophila homolog of the polyglutamine disease gene SCA2 is a dosage-sensitive regulator of actin filament formation. , 2002, Genetics.
[53] R. Nussbaum,et al. The fragile X mental retardation syndrome protein interacts with novel homologs FXR1 and FXR2. , 1995, The EMBO journal.
[54] James R. Burke,et al. Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines , 2002, Nature Neuroscience.
[55] L. Balcer,et al. Friedreich ataxia: effects of genetic understanding on clinical evaluation and therapy. , 2002, Archives of neurology.
[56] Làszlò Tora,et al. Ataxin-7 is a subunit of GCN5 histone acetyltransferase-containing complexes. , 2004, Human molecular genetics.
[57] J. Gécz,et al. Gene structure and subcellular localization of FMR2, a member of a new family of putative transcription activators. , 1997, Genomics.
[58] P. Jin,et al. New insights into fragile X syndrome: from molecules to neurobehaviors. , 2003, Trends in biochemical sciences.
[59] D. Chakravarti,et al. Ataxin-3 Is a Histone-binding Protein with Two Independent Transcriptional Corepressor Activities* , 2002, The Journal of Biological Chemistry.
[60] C. Harrison,et al. The fragile X: a scanning electron microscope study. , 1983, Journal of medical genetics.
[61] T. Ashizawa,et al. The role of ataxin 10 in the pathogenesis of spinocerebellar ataxia type 10 , 2006, Neurology.
[62] R. Albin,et al. Widespread expression of the human and rat Huntington's disease gene in brain and nonneural tissues , 1993, Nature Genetics.
[63] D. Housman,et al. Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila , 2001, Nature.
[64] H. Paulson,et al. Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70 , 1999, Nature Genetics.
[65] M. Swanson,et al. Identification of a (CUG)n triplet repeat RNA-binding protein and its expression in myotonic dystrophy. , 1996, Nucleic acids research.
[66] C. Ware,et al. Polyglutamine-Expanded Ataxin-7 Antagonizes CRX Function and Induces Cone-Rod Dystrophy in a Mouse Model of SCA7 , 2001, Neuron.
[67] Tim-Rasmus Kiehl,et al. Generation and characterization of Sca2 (ataxin-2) knockout mice. , 2006, Biochemical and biophysical research communications.
[68] H. Orr,et al. Beyond the Qs in the polyglutamine diseases. , 2001, Genes & development.
[69] Ruth Luthi-Carter,et al. Histone Deacetylase Inhibition by Sodium Butyrate Chemotherapy Ameliorates the Neurodegenerative Phenotype in Huntington's Disease Mice , 2003, The Journal of Neuroscience.
[70] R. E. Hughes. Polyglutamine Disease: Acetyltransferases Awry , 2002, Current Biology.
[71] D. Housman,et al. Expansion of a CUG trinucleotide repeat in the 3' untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[72] B. Chait,et al. Polyglutamine-expanded ataxin-7 inhibits STAGA histone acetyltransferase activity to produce retinal degeneration. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[73] G. K. Henry,et al. INFORMATION PROCESSING SPEED OF CHILDREN WITH FRIEDREICH'S ATAXIA , 1986, Developmental medicine and child neurology.
[74] H. Lehrach,et al. A protein interaction network links GIT1, an enhancer of huntingtin aggregation, to Huntington's disease. , 2004, Molecular cell.
[75] William B. Dobyns,et al. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the α1A-voltage-dependent calcium channel , 1997, Nature Genetics.
[76] J. Santamaria,et al. A family with adult spinal and bulbar muscular atrophy, X-linked inheritance and associated testicular failure , 1983, Journal of the Neurological Sciences.
[77] C. B. Smith,et al. Postadolescent Changes in Regional Cerebral Protein Synthesis: An In Vivo Study in the Fmr1 Null Mouse , 2005, The Journal of Neuroscience.
[78] Huiyi Wang,et al. Castration Restores Function and Neurofilament Alterations of Aged Symptomatic Males in a Transgenic Mouse Model of Spinal and Bulbar Muscular Atrophy , 2004, The Journal of Neuroscience.
[79] J. Rossi,et al. Hammerhead ribozyme-mediated destruction of nuclear foci in myotonic dystrophy myoblasts. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.
[80] Changming Sun,et al. Spinocerebellar ataxia type 2 presenting as familial levodopa‐responsive parkinsonism , 2001, Annals of neurology.
[81] S. Newfeld,et al. A screen for modifiers of decapentaplegic mutant phenotypes identifies lilliputian, the only member of the Fragile-X/Burkitt's Lymphoma family of transcription factors in Drosophila melanogaster. , 2001, Genetics.
[82] J. Yates,et al. Polyglutamine-expanded spinocerebellar ataxia-7 protein disrupts normal SAGA and SLIK histone acetyltransferase activity. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[83] Barrington G. Burnett,et al. The polyglutamine neurodegenerative protein ataxin-3 binds polyubiquitylated proteins and has ubiquitin protease activity. , 2003, Human molecular genetics.
[84] S. Perlman,et al. Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia , 2006, Nature chemical biology.
[85] S. Hirai,et al. Ataxin-3 Is Translocated into the Nucleus for the Formation of Intranuclear Inclusions in Normal and Machado–Joseph Disease Brains , 2000, Experimental Neurology.
[86] Scott T. Brady,et al. Neuropathogenic Forms of Huntingtin and Androgen Receptor Inhibit Fast Axonal Transport , 2003, Neuron.
[87] S. Floresco,et al. Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes , 1995, Cell.
[88] L. Ranum,et al. Pathogenic RNA repeats: an expanding role in genetic disease. , 2004, Trends in genetics : TIG.
[89] B. D. de Vries,et al. The fragile X syndrome. , 1998, Journal of medical genetics.
[90] J. Bell,et al. A PEDIGREE OF MENTAL DEFECT SHOWING SEX-LINKAGE , 1943, Journal of neurology and psychiatry.
[91] Robert Tjian,et al. Eukaryotic coactivators associated with the TATA box binding protein , 1992 .
[92] K. M. Huber,et al. Metabotropic receptor-dependent long-term depression persists in the absence of protein synthesis in the mouse model of fragile X syndrome. , 2006, Journal of neurophysiology.
[93] M. MacDonald,et al. HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism. , 2005, Human molecular genetics.
[94] Heather A. O'Neill,et al. Yeast Frataxin Sequentially Chaperones and Stores Iron by Coupling Protein Assembly with Iron Oxidation* , 2003, Journal of Biological Chemistry.
[95] H. Zoghbi,et al. Over-expression of inducible HSP70 chaperone suppresses neuropathology and improves motor function in SCA1 mice. , 2001, Human molecular genetics.
[96] J. Sutcliffe,et al. Variation of the CGG repeat at the fragile X site results in genetic instability: Resolution of the Sherman paradox , 1991, Cell.
[97] H. Lubs. A marker X chromosome. , 1969, American journal of human genetics.
[98] S Kobayashi,et al. A neurological disease caused by an expanded CAG trinucleotide repeat in the TATA-binding protein gene: a new polyglutamine disease? , 1999, Human molecular genetics.
[99] Jiandie D. Lin,et al. Defects in Adaptive Energy Metabolism with CNS-Linked Hyperactivity in PGC-1α Null Mice , 2004, Cell.
[100] W. Brown,et al. Fragile X premutation is a significant risk factor for premature ovarian failure: the International Collaborative POF in Fragile X study--preliminary data. , 1999, American journal of medical genetics.
[101] S. Zeitlin,et al. Deletion of the triplet repeat encoding polyglutamine within the mouse Huntington's disease gene results in subtle behavioral/motor phenotypes in vivo and elevated levels of ATP with cellular senescence in vitro. , 2006, Human molecular genetics.
[102] I. G. Fantus,et al. Glucose intolerance in first-degree relatives of patients with Friedreich's ataxia is associated with insulin resistance: evidence for a closely linked inherited trait. , 1991, Metabolism: clinical and experimental.
[103] Christopher A Ross,et al. Widespread expression of Huntington's disease gene (IT15) protein product , 1995, Neuron.
[104] H. Zoghbi,et al. Impaired Conditioned Fear and Enhanced Long-Term Potentiation inFmr2 Knock-Out Mice , 2002, The Journal of Neuroscience.
[105] W. Brown,et al. Fmr1 knockout mouse has a distinctive strain-specific learning impairment , 2000, Neuroscience.
[106] J. Melki,et al. Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits , 2001, Nature Genetics.
[107] Leslie M Thompson,et al. Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[108] Sanne de Wit,et al. Behavioral and neuroanatomical characterization of the Fmr1 knockout mouse , 2002, Hippocampus.
[109] Fumiaki Tanaka,et al. Sodium butyrate ameliorates phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. , 2004, Human molecular genetics.
[110] M. MacDonald,et al. Early phenotypes that presage late-onset neurodegenerative disease allow testing of modifiers in Hdh CAG knock-in mice. , 2002, Human molecular genetics.
[111] T. Cooper,et al. RNA-mediated neuromuscular disorders. , 2006, Annual review of neuroscience.
[112] J. Rommens,et al. Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy , 1998, Nature Genetics.
[113] H. Zoghbi,et al. A Long CAG Repeat in the Mouse Sca1 Locus Replicates SCA1 Features and Reveals the Impact of Protein Solubility on Selective Neurodegeneration , 2002, Neuron.
[114] A. Young. Huntingtin in health and disease. , 2003, The Journal of clinical investigation.
[115] S. Warren,et al. Acetylated histones are associated with FMR1 in normal but not fragile X-syndrome cells , 1999, Nature Genetics.
[116] Harry T Orr,et al. RNA association and nucleocytoplasmic shuttling by ataxin-1 , 2005, Journal of Cell Science.
[117] F. Westermann,et al. Ataxin-2 promotes apoptosis of human neuroblastoma cells , 2003, Oncogene.
[118] A. Munnich,et al. Disabled early recruitment of antioxidant defenses in Friedreich's ataxia. , 2001, Human molecular genetics.
[119] M. Hayden,et al. Nuclear Localization of a Non-caspase Truncation Product of Atrophin-1, with an Expanded Polyglutamine Repeat, Increases Cellular Toxicity* , 2003, The Journal of Biological Chemistry.
[120] P. Worley,et al. Huntingtin-associated protein 1 (HAP1) interacts with the p150Glued subunit of dynactin. , 1997, Human molecular genetics.
[121] Richard Paylor,et al. Dynamic Translational and Proteasomal Regulation of Fragile X Mental Retardation Protein Controls mGluR-Dependent Long-Term Depression , 2006, Neuron.
[122] G. Campanella,et al. Otoneurological findings in Friedreich's ataxia and other inherited neuropathies. , 1986, Audiology : official organ of the International Society of Audiology.
[123] A. Paetau,et al. Histopathological differences of myotonic dystrophy type 1 (DM1) and PROMM/DM2 , 2003, Neurology.
[124] Juan Botas,et al. The AXH Domain of Ataxin-1 Mediates Neurodegeneration through Its Interaction with Gfi-1/Senseless Proteins , 2005, Cell.
[125] Richard G. Brusch,et al. Disruption of Axonal Transport by Loss of Huntingtin or Expression of Pathogenic PolyQ Proteins in Drosophila , 2003, Neuron.
[126] Hung-Ying Kao,et al. Ataxin 1, a SCA1 neurodegenerative disorder protein, is functionally linked to the silencing mediator of retinoid and thyroid hormone receptors , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[127] R Greim,et al. Exon/intron structure of the human AF‐4 gene, a member of the AF‐4/LAF‐4/FMR‐2 gene family coding for a nuclear protein with structural alterations in acute leukaemia , 1997, British journal of haematology.
[128] O. Onodera,et al. Unstable expansion of CAG repeat in hereditary dentatorubral–pallidoluysian atrophy (DRPLA) , 1994, Nature Genetics.
[129] Thomas Lengauer,et al. An integrative approach to gain insights into the cellular function of human ataxin-2. , 2005, Journal of molecular biology.
[130] Harry T Orr,et al. Ataxin-1 Nuclear Localization and Aggregation Role in Polyglutamine-Induced Disease in SCA1 Transgenic Mice , 1998, Cell.
[131] N. Funata,et al. Recruitment of Nonexpanded Polyglutamine Proteins to Intranuclear Aggregates in Neuronal Intranuclear Hyaline Inclusion Disease , 2001, Journal of neuropathology and experimental neurology.
[132] He Li,et al. Interaction of Huntington Disease Protein with Transcriptional Activator Sp1 , 2002, Molecular and Cellular Biology.
[133] K. Hofmann,et al. Elucidation of ataxin-3 and ataxin-7 function by integrative bioinformatics. , 2003, Human molecular genetics.
[134] Mark F. Bear,et al. Altered synaptic plasticity in a mouse model of fragile X mental retardation , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[135] K. Fischbeck,et al. Therapeutics development for triplet repeat expansion diseases , 2005, Nature Reviews Genetics.
[136] Peter K. Todd,et al. The fragile X mental retardation protein is required for type-I metabotropic glutamate receptor-dependent translation of PSD-95 , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[137] Kiyoshi Iwabuchi,et al. Non-expanded polyglutamine proteins in intranuclear inclusions of hereditary ataxias – triple-labeling immunofluorescence study , 2001, Acta Neuropathologica.
[138] T. Bird,et al. An untranslated CTG expansion causes a novel form of spinocerebellar ataxia (SCA8) , 1999, Nature Genetics.
[139] D. Nelson,et al. Exaggerated behavioral phenotypes in Fmr1/Fxr2 double knockout mice reveal a functional genetic interaction between Fragile X-related proteins. , 2006, Human molecular genetics.
[140] A T Hoogeveen,et al. FMRP is associated to the ribosomes via RNA. , 1996, Human molecular genetics.
[141] M. Lentze,et al. A novel stable polyalanine [poly(A)] expansion in the HOXA13 gene associated with hand-foot-genital syndrome: proper function of poly(A)-harbouring transcription factors depends on a critical repeat length? , 2002, Human Genetics.
[142] Y. Agid,et al. Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion , 1997, Nature Genetics.
[143] A. Smith,et al. Müller-cell-derived leukaemia inhibitory factor arrests rod photoreceptor differentiation at a postmitotic pre-rod stage of development. , 1997, Development.
[144] C. Sewry,et al. Flies deficient in Muscleblind protein model features of myotonic dystrophy with altered splice forms of Z-band associated transcripts , 2006, Human Genetics.
[145] E. De Schutter,et al. Deletion of FMR1 in Purkinje Cells Enhances Parallel Fiber LTD, Enlarges Spines, and Attenuates Cerebellar Eyelid Conditioning in Fragile X Syndrome , 2005, Neuron.
[146] J Grigsby,et al. Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS). , 2006, Brain : a journal of neurology.
[147] S. Batalov,et al. Ubiquitin-mediated sequestration of normal cellular proteins into polyglutamine aggregates , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[148] Effat S. Emamian,et al. Serine 776 of Ataxin-1 Is Critical for Polyglutamine-Induced Disease in SCA1 Transgenic Mice , 2003, Neuron.
[149] S. Cannon,et al. Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy. , 2002, Molecular cell.
[150] K. Fischbeck,et al. Inactivation of the Friedreich ataxia mouse gene leads to early embryonic lethality without iron accumulation. , 2000, Human molecular genetics.
[151] T. Cooper,et al. Colocalization of muscleblind with RNA foci is separable from mis-regulation of alternative splicing in myotonic dystrophy , 2005, Journal of Cell Science.
[152] M. D. Del Bigio,et al. Neuronal intranuclear inclusions in a new cerebellar tremor/ataxia syndrome among fragile X carriers. , 2002, Brain : a journal of neurology.
[153] Tian Xu,et al. Drosophila Atrophin Homolog Functions as a Transcriptional Corepressor in Multiple Developmental Processes , 2002, Cell.
[154] R. Gibbs,et al. Identification of FMR2, a novel gene associated with the FRAXE CCG repeat and CpG island , 1996, Nature Genetics.
[155] P Trouillas,et al. Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes. , 1997, Human molecular genetics.
[156] M. Pandolfo,et al. Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin. , 1997, Science.
[157] I. Weiler,et al. Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: a quantitative examination. , 2001, American journal of medical genetics.
[158] J. Nemes,et al. The SCA8 transcript is an antisense RNA to a brain-specific transcript encoding a novel actin-binding protein (KLHL1). , 2000, Human molecular genetics.
[159] A. Munnich,et al. Effect of idebenone on cardiomyopathy in Friedreich's ataxia: a preliminary study , 1999, The Lancet.
[160] L. Pallanck,et al. Ataxin-2 and its Drosophila homolog, ATX2, physically assemble with polyribosomes. , 2006, Human molecular genetics.
[161] Heather A. O'Neill,et al. Frataxin Acts as an Iron Chaperone Protein to Modulate Mitochondrial Aconitase Activity , 2004, Science.
[162] E. Wilson,et al. The androgen receptor: an overview. , 1994, Recent progress in hormone research.
[163] S. Naylor,et al. Myotonic Dystrophy Type 2 Caused by a CCTG Expansion in Intron 1 of ZNF9 , 2001, Science.
[164] P. Hagerman,et al. Fragile-X syndrome and fragile X-associated tremor/ataxia syndrome: two faces of FMR1 , 2007, The Lancet Neurology.
[165] Michael Courtois,et al. PGC-1α Deficiency Causes Multi-System Energy Metabolic Derangements: Muscle Dysfunction, Abnormal Weight Control and Hepatic Steatosis , 2005, PLoS Biology.
[166] É. Khandjian,et al. Intranuclear inclusions in neural cells with premutation alleles in fragile X associated tremor/ataxia syndrome , 2004, Journal of Medical Genetics.
[167] I. Kanazawa,et al. SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein. , 2001, Human molecular genetics.
[168] R. Tjian,et al. In Vitro Analysis of Huntingtin-Mediated Transcriptional Repression Reveals Multiple Transcription Factor Targets , 2005, Cell.
[169] H. Zoghbi,et al. Gene profiling links SCA1 pathophysiology to glutamate signaling in Purkinje cells of transgenic mice. , 2004, Human molecular genetics.
[170] R. Jensen,et al. Suppression of a defect in mitochondrial protein import identifies cytosolic proteins required for viability of yeast cells lacking mitochondrial DNA. , 2003, Genetics.
[171] J. Gusella,et al. The predominantly HEAT-like motif structure of huntingtin and its association and coincident nuclear entry with dorsal, an NF-kB/Rel/dorsal family transcription factor , 2002, BMC Neuroscience.
[172] M. MacDonald,et al. Huntingtin: Alive and Well and Working in Middle Management , 2003, Science's STKE.
[173] H. Paulson,et al. Ataxin-3 suppresses polyglutamine neurodegeneration in Drosophila by a ubiquitin-associated mechanism. , 2005, Molecular cell.
[174] A. Jacobson,et al. Pbp1p, a Factor Interacting withSaccharomyces cerevisiae Poly(A)-Binding Protein, Regulates Polyadenylation , 1998, Molecular and Cellular Biology.
[175] A. Spada,et al. Bergmann glia expression of polyglutamine-expanded ataxin-7 produces neurodegeneration by impairing glutamate transport , 2006, Nature Neuroscience.
[176] J S Child,et al. Cardiac involvement in Friedreich's ataxia: a clinical study of 75 patients. , 1986, Journal of the American College of Cardiology.
[177] A. Munnich,et al. Aconitase and mitochondrial iron–sulphur protein deficiency in Friedreich ataxia , 1997, Nature Genetics.
[178] W. Hauswirth,et al. A Muscleblind Knockout Model for Myotonic Dystrophy , 2003, Science.
[179] Peng Jin,et al. RNA-Mediated Neurodegeneration Caused by the Fragile X Premutation rCGG Repeats in Drosophila , 2003, Neuron.
[180] S. Pulst,et al. Nuclear localization or inclusion body formation of ataxin-2 are not necessary for SCA2 pathogenesis in mouse or human , 2000, Nature Genetics.
[181] Virginia E. Papaioannou,et al. Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue , 1995, Nature Genetics.
[182] J. Darnell,et al. Microarray Identification of FMRP-Associated Brain mRNAs and Altered mRNA Translational Profiles in Fragile X Syndrome , 2001, Cell.
[183] M. Koenig,et al. Friedreich ataxia: the oxidative stress paradox. , 2005, Human molecular genetics.
[184] A Dürr,et al. Clinical and genetic abnormalities in patients with Friedreich's ataxia. , 1996, The New England journal of medicine.
[185] H. Zoghbi,et al. The spinocerebellar ataxia type 1 protein, ataxin-1, has RNA-binding activity that is inversely affected by the length of its polyglutamine tract. , 2001, Human molecular genetics.
[186] G. Sobue,et al. Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy , 2003, Nature Medicine.
[187] Huda Y. Zoghbi,et al. Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1 , 1993, Nature Genetics.
[188] M. Ristow,et al. The yeast frataxin homolog Yfh1p plays a specific role in the maturation of cellular Fe/S proteins. , 2002, Human molecular genetics.
[189] T. Cooper,et al. Pre-mRNA splicing and human disease. , 2003, Genes & development.
[190] B. Oostra,et al. Immunocytochemical and biochemical characterization of FMRP, FXR1P, and FXR2P in the mouse. , 2000, Experimental cell research.
[191] Pier Paolo Di Fiore,et al. Deubiquitinating function of ataxin-3: insights from the solution structure of the Josephin domain. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[192] Guy Nagels,et al. Fmr1 knockout mice: A model to study fragile X mental retardation , 1994, Cell.
[193] C. Ross,et al. Protein aggregation and neurodegenerative disease , 2004, Nature Medicine.
[194] H. Zoghbi,et al. Identification of genes that modify ataxin-1-induced neurodegeneration , 2000, Nature.
[195] S. Luquet,et al. Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration. , 2006, Cell metabolism.
[196] G. Kozlov,et al. Structure and function of the C-terminal PABC domain of human poly(A)-binding protein , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[197] A. Berns,et al. Abnormal myotonic dystrophy protein kinase levels produce only mild myopathy in mice , 1996, Nature Genetics.
[198] R. D'Hooge,et al. Mildly impaired water maze performance in maleFmr1 knockout mice , 1997, Neuroscience.
[199] L. Thompson,et al. Targeting aggregation in the development of therapeutics for the treatment of Huntington’s disease and other polyglutamine repeat diseases , 2003, Expert opinion on therapeutic targets.
[200] R. J. White,et al. Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. , 2000, Science.
[201] R. Griggs,et al. Decreased insulin sensitivity of forearm muscle in myotonic dystrophy. , 1978, The Journal of clinical investigation.
[202] P G Bhide,et al. Expression of Normal and Mutant Huntingtin in the Developing Brain , 1996, The Journal of Neuroscience.
[203] C. Gomez,et al. C-termini of P/Q-type Ca2+ channel alpha1A subunits translocate to nuclei and promote polyglutamine-mediated toxicity. , 2006, Human molecular genetics.
[204] C A Ross,et al. Interference by Huntingtin and Atrophin-1 with CBP-Mediated Transcription Leading to Cellular Toxicity , 2001, Science.
[205] M. Muratani,et al. How the ubiquitin–proteasome system controls transcription , 2003, Nature Reviews Molecular Cell Biology.
[206] S. W. Davies,et al. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. , 1997, Science.
[207] D. Hilton‐Jones,et al. Clinical and molecular aspects of the myotonic dystrophies: A review , 2005, Muscle & nerve.
[208] B. Birren,et al. Disruption of the nuclear hormone receptor RORα in staggerer mice , 1996, Nature.
[209] M. Beal,et al. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases , 2006, Nature.
[210] P. Patel,et al. Friedreich's Ataxia: Autosomal Recessive Disease Caused by an Intronic GAA Triplet Repeat Expansion , 1996, Science.
[211] G. Sutherland. Fragile sites on human chromosomes: demonstration of their dependence on the type of tissue culture medium. , 1977, Science.
[212] T. Webb,et al. Prevalence of fragile X syndrome. , 1996, Journal of medical genetics.
[213] L. Raymond,et al. Cleavage at the Caspase-6 Site Is Required for Neuronal Dysfunction and Degeneration Due to Mutant Huntingtin , 2006, Cell.
[214] M. Swanson,et al. Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2. , 2001, Human molecular genetics.
[215] C. Ehresmann,et al. The fragile X mental retardation protein binds specifically to its mRNA via a purine quartet motif , 2001, The EMBO journal.
[216] S. T. Warren,et al. Fragile X mouse: strain effects of knockout phenotype and evidence suggesting deficient amygdala function , 1999, Neuroscience.
[217] M. Mutsuddi,et al. The Spinocerebellar Ataxia 8 Noncoding RNA Causes Neurodegeneration and Associates with Staufen in Drosophila , 2004, Current Biology.
[218] D. Nelson,et al. (Over)correction of FMR1 deficiency with YAC transgenics: behavioral and physical features. , 2000, Human molecular genetics.
[219] B. W. Richards,et al. Fragile X-linked mental retardation: the Martin-Bell syndrome. , 2008, Journal of mental deficiency research.
[220] T. Cooper,et al. Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy , 2001, Nature Genetics.
[221] T. Godfrey,et al. Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome. , 2000, American journal of human genetics.
[222] S. Hersch,et al. Identification and localization of huntingtin in brain and human lymphoblastoid cell lines with anti-fusion protein antibodies. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[223] J. Darnell,et al. Fragile X Mental Retardation Protein Targets G Quartet mRNAs Important for Neuronal Function , 2001, Cell.
[224] J. Olson,et al. Polyglutamine and transcription: gene expression changes shared by DRPLA and Huntington's disease mouse models reveal context-independent effects. , 2002, Human molecular genetics.
[225] D. Housman,et al. Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy , 1996, Nature Genetics.
[226] I. Weiler,et al. Fragile X mental retardation protein is necessary for neurotransmitter-activated protein translation at synapses. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[227] B. Schmidt,et al. Expression of X-linked bulbospinal muscular atrophy (Kennedy disease) in two homozygous women. , 2002, Neurology.
[228] A. Delacourte,et al. Mice transgenic for the human myotonic dystrophy region with expanded CTG repeats display muscular and brain abnormalities. , 2001, Human molecular genetics.
[229] Fabrice P Cordelières,et al. Huntingtin Controls Neurotrophic Support and Survival of Neurons by Enhancing BDNF Vesicular Transport along Microtubules , 2004, Cell.
[230] G. Guillén,et al. Ubiquitous expression of human SCA2 gene under the regulation of the SCA2 self promoter cause specific Purkinje cell degeneration in transgenic mice , 2006, Neuroscience Letters.
[231] Daniela C. Zarnescu,et al. Biochemical and genetic interaction between the fragile X mental retardation protein and the microRNA pathway , 2004, Nature Neuroscience.
[232] S. Narumiya,et al. Expanded polyglutamine in the Machado–Joseph disease protein induces cell death in vitro and in vivo , 1996, Nature Genetics.
[233] René Hen,et al. Reversal of Neuropathology and Motor Dysfunction in a Conditional Model of Huntington's Disease , 2000, Cell.
[234] M. Hayden,et al. Absence of behavioral abnormalities and neurodegeneration in vivo despite widespread neuronal huntingtin inclusions. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[235] K. Fischbeck,et al. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy , 1991, Nature.
[236] H. Zoghbi,et al. Neuronal dysfunction in a polyglutamine disease model occurs in the absence of ubiquitin-proteasome system impairment and inversely correlates with the degree of nuclear inclusion formation. , 2005, Human molecular genetics.
[237] Georg Auburger,et al. Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2 , 1996, Nature Genetics.
[238] M. Meyer,et al. Molecular and clinical findings in a family with dentatorubral‐pallidoluysian atrophy , 1995, Annals of neurology.
[239] M. Sanders,et al. Autosomal dominant cerebellar ataxia with pigmentary macular dystrophy. A clinical and genetic study of eight families. , 1994, Brain : a journal of neurology.
[240] S. W. Davies,et al. Exon 1 of the HD Gene with an Expanded CAG Repeat Is Sufficient to Cause a Progressive Neurological Phenotype in Transgenic Mice , 1996, Cell.
[241] H. Zoghbi,et al. RORα-Mediated Purkinje Cell Development Determines Disease Severity in Adult SCA1 Mice , 2006, Cell.
[242] G Campanella,et al. The relationship between trinucleotide (GAA) repeat length and clinical features in Friedreich ataxia. , 1996, American journal of human genetics.
[243] Yan Wang,et al. Pharmacological Rescue of Synaptic Plasticity, Courtship Behavior, and Mushroom Body Defects in a Drosophila Model of Fragile X Syndrome , 2005, Neuron.
[244] Steven Finkbeiner,et al. Huntingtin Acts in the Nucleus to Induce Apoptosis but Death Does Not Correlate with the Formation of Intranuclear Inclusions , 1998, Cell.
[245] T. Schulz,et al. Targeted disruption of hepatic frataxin expression causes impaired mitochondrial function, decreased life span and tumor growth in mice. , 2005, Human molecular genetics.
[246] C. E. Pearson,et al. Evidence of cis-acting factors in replication-mediated trinucleotide repeat instability in primate cells , 2002, Nature Genetics.
[247] M. Koenig,et al. Friedreich ataxia: a paradigm for mitochondrial diseases. , 2002, Current opinion in genetics & development.
[248] C. Ware,et al. Polyglutamine-Expanded Ataxin-7 Promotes Non-Cell-Autonomous Purkinje Cell Degeneration and Displays Proteolytic Cleavage in Ataxic Transgenic Mice , 2002, The Journal of Neuroscience.
[249] F. Porteu,et al. Cloning and Characterization of a Family of Proteins Associated with Mpl* , 2002, The Journal of Biological Chemistry.
[250] H. Zoghbi,et al. Mouse and fly models of neurodegeneration. , 2002, Trends in genetics : TIG.
[251] B. Oostra,et al. In vitro reactivation of the FMR1 gene involved in fragile X syndrome. , 1998, Human molecular genetics.
[252] W. Alaynick,et al. Boat, an AXH domain protein, suppresses the cytotoxicity of mutant ataxin‐1 , 2005, The EMBO journal.
[253] D. Absher,et al. FMRP associates with polyribosomes as an mRNP, and the I304N mutation of severe fragile X syndrome abolishes this association. , 1997, Molecular cell.
[254] S. Eddy,et al. Kissing complex RNAs mediate interaction between the Fragile-X mental retardation protein KH2 domain and brain polyribosomes. , 2005, Genes & development.
[255] T. Cooper,et al. Dynamic balance between activation and repression regulates pre‐mRNA alternative splicing during heart development , 2005, Developmental dynamics : an official publication of the American Association of Anatomists.
[256] T. Cooper,et al. Insulin receptor splicing alteration in myotonic dystrophy type 2. , 2004, American journal of human genetics.
[257] T. Ebner,et al. Bidirectional expression of CUG and CAG expansion transcripts and intranuclear polyglutamine inclusions in spinocerebellar ataxia type 8 , 2006, Nature Genetics.
[258] S. Tapscott,et al. Myotonic dystrophy: emerging mechanisms for DM1 and DM2. , 2007, Biochimica et biophysica acta.
[259] Dimitri Krainc,et al. Sp1 and TAFII130 Transcriptional Activity Disrupted in Early Huntington's Disease , 2002, Science.
[260] Shigenobu Nakamura,et al. CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1 , 1994, Nature Genetics.
[261] S. Hersch,et al. Interaction of Huntingtin-Associated Protein with Dynactin P150Glued , 1998, The Journal of Neuroscience.
[262] S. Pulst,et al. Expression of ataxin‐2 in brains from normal individuals and patients with Alzheimer's disease and spinocerebellar ataxia 2 , 1999, Annals of neurology.
[263] F. Foury,et al. Deletion of the yeast homologue of the human gene associated with Friedreich's ataxia elicits iron accumulation in mitochondria , 1997, FEBS letters.
[264] Andrea Crotti,et al. Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes , 2003, Nature Genetics.
[265] T. Tabata,et al. Androgen-Dependent Neurodegeneration by Polyglutamine-Expanded Human Androgen Receptor in Drosophila , 2002, Neuron.
[266] R. Kopito,et al. Aggresomes, inclusion bodies and protein aggregation. , 2000, Trends in cell biology.
[267] Kendal Broadie,et al. The Drosophila Fragile X Gene Negatively Regulates Neuronal Elaboration and Synaptic Differentiation , 2004, Current Biology.
[268] Rodney C. Samaco,et al. Duplication of Atxn1l suppresses SCA1 neuropathology by decreasing incorporation of polyglutamine-expanded ataxin-1 into native complexes , 2007, Nature Genetics.
[269] J. Cowan,et al. Iron-sulfur cluster biosynthesis. Characterization of frataxin as an iron donor for assembly of [2Fe-2S] clusters in ISU-type proteins. , 2003, Journal of the American Chemical Society.
[270] H. Zoghbi,et al. Glutamine repeats and neurodegeneration. , 2000, Annual review of neuroscience.
[271] S. Warren,et al. The fragile X mental retardation protein inhibits translation via interacting with mRNA. , 2001, Nucleic acids research.
[272] Harry T Orr,et al. Targeted Deletion of a Single Sca8 Ataxia Locus Allele in Mice Causes Abnormal Gait, Progressive Loss of Motor Coordination, and Purkinje Cell Dendritic Deficits , 2006, The Journal of Neuroscience.
[273] Olaf Riess,et al. Clinical features and neuropathology of autosomal dominant spinocerebellar ataxia (SCA17) , 2003, Annals of neurology.
[274] R I Richards,et al. Dynamic mutations: a decade of unstable expanded repeats in human genetic disease. , 2001, Human molecular genetics.
[275] S. Folstein,et al. Huntington's disease gene (IT15) is widely expressed in human and rat tissues , 1993, Neuron.
[276] R. Ferrante,et al. Neuropathological Classification of Huntington's Disease , 1985, Journal of neuropathology and experimental neurology.
[277] Melvin G McInnis,et al. Expansion of a novel CAG trinucleotide repeat in the 5′ region of PPP2R2B is associated with SCA12 , 1999, Nature Genetics.
[278] P. Harper,et al. Genetic risks for children of women with myotonic dystrophy. , 1991, American journal of human genetics.
[279] H. Zoghbi,et al. Expression analysis of the ataxin–1 protein in tissues from normal and spinocerebellar ataxia type 1 individuals , 1995, Nature Genetics.
[280] M. Mahadevan,et al. Reversible model of RNA toxicity and cardiac conduction defects in myotonic dystrophy , 2006, Nature Genetics.
[281] P. Hagerman,et al. Protein composition of the intranuclear inclusions of FXTAS. , 2006, Brain : a journal of neurology.
[282] P. Hagerman,et al. The fragile-X premutation: a maturing perspective. , 2004, American journal of human genetics.
[283] T. Cooper,et al. MBNL1 and CUGBP1 modify expanded CUG-induced toxicity in a Drosophila model of myotonic dystrophy type 1. , 2006, Human molecular genetics.
[284] S. Puglisi‐Allegra,et al. Object recognition impairment in Fmr1 knockout mice is reversed by amphetamine: involvement of dopamine in the medial prefrontal cortex , 2004, Behavioural pharmacology.
[285] Michael S. Levine,et al. Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice , 2000, Nature Genetics.
[286] A. Dancis,et al. Iron use for haeme synthesis is under control of the yeast frataxin homologue (Yfh1). , 2003, Human molecular genetics.
[287] G. Sobue,et al. Testosterone Reduction Prevents Phenotypic Expression in a Transgenic Mouse Model of Spinal and Bulbar Muscular Atrophy , 2002, Neuron.
[288] Edwin J. Weeber,et al. SCA7 Knockin Mice Model Human SCA7 and Reveal Gradual Accumulation of Mutant Ataxin-7 in Neurons and Abnormalities in Short-Term Plasticity , 2003, Neuron.
[289] T. Cooper,et al. Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing. , 2002, Molecular cell.
[290] D. Crawford,et al. Paternally transmitted FMR1 alleles are less stable than maternally transmitted alleles in the common and intermediate size range. , 2002, American journal of human genetics.
[291] Erich E Wanker,et al. The hunt for huntingtin function: interaction partners tell many different stories. , 2003, Trends in biochemical sciences.
[292] H. Zoghbi,et al. Glutamine-Expanded Ataxin-7 Alters TFTC/STAGA Recruitment and Chromatin Structure Leading to Photoreceptor Dysfunction , 2006, PLoS biology.
[293] T. Ashizawa,et al. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. , 1992, Science.
[294] E. Hafen,et al. Lilliputian: an AF4/FMR2-related protein that controls cell identity and cell growth. , 2001, Development.
[295] C. Duyckaerts,et al. Amyotrophic lateral sclerosis with neuronal intranuclear protein inclusions , 2004, Acta Neuropathologica.
[296] H. Paulson,et al. Poly-ubiquitin Binding by the Polyglutamine Disease Protein Ataxin-3 Links Its Normal Function to Protein Surveillance Pathways* , 2004, Journal of Biological Chemistry.
[297] H. Zoghbi,et al. SUMOylation of the Polyglutamine Repeat Protein, Ataxin-1, Is Dependent on a Functional Nuclear Localization Signal* , 2005, Journal of Biological Chemistry.
[298] Huda Y. Zoghbi,et al. Diseases of Unstable Repeat Expansion: Mechanisms and Common Principles , 2005, Nature Reviews Genetics.
[299] I. Kanazawa,et al. Interaction between Mutant Ataxin-1 and PQBP-1 Affects Transcription and Cell Death , 2002, Neuron.
[300] J. Skinner,et al. Localization of the fragile X mental retardation 2 (FMR2) protein in mammalian brain , 2000, The European journal of neuroscience.
[301] J. Sutcliffe,et al. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome , 1991, Cell.
[302] T. Klockgether,et al. SCA6 is caused by moderate CAG expansion in the alpha1A-voltage-dependent calcium channel gene. , 1997, Human molecular genetics.
[303] S. di Donato,et al. Idebenone treatment in Friedreich patients: One-year-long randomized placebo-controlled trial , 2003, Neurology.
[304] S. Pulst,et al. A novel protein with RNA-binding motifs interacts with ataxin-2. , 2000, Human molecular genetics.
[305] J. Nemes,et al. Erratum: The SCA8 transcript is an antisense RNA to a brain-specific transcript encoding a novel actin-binding protein (KLHL1) (Human Molecular Genetics (2000) vol. 9 (1543-1551)) , 2000 .
[306] G. Pigino,et al. JNK mediates pathogenic effects of polyglutamine-expanded androgen receptor on fast axonal transport , 2006, Nature Neuroscience.
[307] J. Opitz,et al. Consideration of connective tissue dysfunction in the fragile X syndrome. , 1984, American journal of medical genetics.
[308] G. Sobue,et al. X-linked recessive bulbospinal neuronopathy. A clinicopathological study. , 1989, Brain : a journal of neurology.
[309] G. Sutherland,et al. Idebenone treatment in Friedreich’s ataxia , 2003, Neurology.
[310] David E. Housman,et al. Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member , 1992, Cell.
[311] K. Davies,et al. Trinucleotide repeat amplification and hypermethylation of a CpG island in FRAXE mental retardation , 1993, Cell.
[312] R. Wilson,et al. Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X , 2001, Neurology.
[313] A. Dejean,et al. Nuclear and unclear functions of SUMO , 2003, Nature Reviews Molecular Cell Biology.
[314] Brigitte Bogert,et al. The fragile X-related Gene Affects the Crawling Behavior of Drosophila Larvae by Regulating the mRNA Level of the DEG/ENaC Protein Pickpocket1 , 2004, Current Biology.
[315] John I. Clark,et al. Mice deficient in Six5 develop cataracts: implications for myotonic dystrophy , 2000, Nature Genetics.
[316] H. Lehrach,et al. Ataxin-3 is transported into the nucleus and associates with the nuclear matrix. , 1998, Human molecular genetics.
[317] C. Pablos,et al. Brain-stem auditory evoked potentials and blink reflex in friedreich's ataxia , 1991, Journal of Neurology.
[318] K. Fischbeck,et al. Altered acetylation in polyglutamine disease: an opportunity for therapeutic intervention? , 2002, Trends in molecular medicine.
[319] D. Black. Mechanisms of alternative pre-messenger RNA splicing. , 2003, Annual review of biochemistry.
[320] J. Gécz,et al. Identification of the gene FMR2, associated with FRAXE mental retardation , 1996, Nature Genetics.
[321] D. Loesch,et al. FRAXE and mental retardation. , 1995, Journal of medical genetics.
[322] J. Sarsero,et al. Upregulation of expression from the FRDA genomic locus for the therapy of Friedreich ataxia , 2003, The journal of gene medicine.
[323] Mariette Schrier,et al. The FMR1 CGG repeat mouse displays ubiquitin-positive intranuclear neuronal inclusions; implications for the cerebellar tremor/ataxia syndrome. , 2003, Human molecular genetics.
[324] P. Friedreich,et al. Ueber degenerative Atrophie der spinalen Hinterstränge , 2005, Archiv für pathologische Anatomie und Physiologie und für klinische Medicin.
[325] A. Ostareck-Lederer,et al. Evidence that fragile X mental retardation protein is a negative regulator of translation. , 2001, Human molecular genetics.
[326] E. Monrós,et al. Friedreich's ataxia: idebenone treatment in early stage patients. , 2002, Neuropediatrics.
[327] Harry T Orr,et al. Mutation of the E6-AP Ubiquitin Ligase Reduces Nuclear Inclusion Frequency While Accelerating Polyglutamine-Induced Pathology in SCA1 Mice , 1999, Neuron.